Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Duke University
Duke University
Kura Oncology, Inc.
Atara Biotherapeutics
Genmab
AbbVie
University of California, San Francisco
ADC Therapeutics S.A.
Seagen Inc.
Molecular Templates, Inc.
Barbara Ann Karmanos Cancer Institute
BTG International Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie